EWM
SGYP

Edge Wealth Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Edge Wealth Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-50
Closed -$1K – 584
2017
Q3 		$1K Hold
50
– – ﹤0.01% 520
2017
Q2 		$1K Hold
50
– – ﹤0.01% 517
2017
Q1 		$1K Hold
50
– – ﹤0.01% 500
2016
Q4 		$1K Hold
50
– – ﹤0.01% 475
2016
Q3 		$1K Hold
50
– – ﹤0.01% 470
2016
Q2 		$0 Hold
50
– – ﹤0.01% 499
2016
Q1 		$1K Hold
50
– – ﹤0.01% 438
2015
Q4 		$1K Sell
50
-1,500
-97% -$9.14K ﹤0.01% 451
2015
Q3 		$8K Buy
+1,550
New +$12K ﹤0.01% 319

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Edge Wealth Management's SGYP Position: Q4 2017 in Review

Edge Wealth Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2017, closing a stake of 50 shares — an estimated $1K sold.

Edge Wealth Management first reported a position in SGYP in Q3 2015 and held it in 9 quarters. The position peaked at $8K in Q3 2015. 150 funds tracked by Wall St. Rank hold SGYP as of Q4 2017.

  • Edge Wealth Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2017 after selling out during the quarter.
  • Edge Wealth Management sold 50 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2017, an estimated $1K.
  • Edge Wealth Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2015 and held it in 9 quarters.
  • Edge Wealth Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $8K in Q3 2015.
  • 150 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2017.

Based on Edge Wealth Management's 13F filing for Q4 2017, filed 18 Jan 2018.